QuickView for Claudin-11 (biogroup)

1. Tim-3 knockdown RAW264.7 monocyte cell line
2. Apollon knockdown in a melanoma cell line treated with fotemustine, PLX4720 or PD0325901
3. L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
4. OMIM - Brain CNS Motor Neuron and other Neuropathy Disorders
5. Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]

There were no matches for Claudin-11

1. Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
2. Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Ca…
3. A Study to Assess the Antitumor Activity, Safety, Pharmacokinetics and Biomarkers of Zolbetuximab (I…
4. Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advan…
5. Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T